Log In
BCIQ
Print this Print this
 

RON2315

  Manage Alerts
Collapse Summary General Information
Company Rogne Bioscience Inc.
DescriptionTopical formulation of a human, naturally occurring 15 amino acid peptide that inhibits production of IL-23 and other inflammatory cytokines
Molecular Target Interleukin-23 (IL-23)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/31/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today